Jiri Eitler

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Translational development and first-in-human compassionate infusion of NK-92 cells expressing a CD5-based chimeric antigen receptor (SRCD5CAR-NK-92) in a patient with multidrug-resistant fusariosis.

Translational development and first-in-human compassionate infusion of NK-92 cells expressing a CD5-based chimeric antigen receptor (SRCD5CAR-NK-92) in a patient with multidrug-resistant fusariosis.

Journal: Frontiers in immunology

Published: December 21, 2025

Dual CAR-NK cells targeting PD-L1 and ErbB2 (HER2) exhibit cooperative CAR signaling and counteract solid tumor heterogeneity.

Dual CAR-NK cells targeting PD-L1 and ErbB2 (HER2) exhibit cooperative CAR signaling and counteract solid tumor heterogeneity.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 12, 2025

Dual CAR-NK cells targeting PD-L1 and ErbB2 (HER2) exhibit cooperative CAR signaling and counteract solid tumor heterogeneity.

Dual CAR-NK cells targeting PD-L1 and ErbB2 (HER2) exhibit cooperative CAR signaling and counteract solid tumor heterogeneity.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 12, 2025

From byproduct to biotherapeutic: Comparative study of buffy coats and leukoreduction system chambers for NK cell-based immunotherapies.

From byproduct to biotherapeutic: Comparative study of buffy coats and leukoreduction system chambers for NK cell-based immunotherapies.

Journal: iScience

Published: July 16, 2025

Radiation-induced morphea of the breast - characterization and treatment of fibroblast dysfunction with repurposed mesalazine.

Radiation-induced morphea of the breast - characterization and treatment of fibroblast dysfunction with repurposed mesalazine.

Journal: Scientific reports

Published: May 21, 2024

CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation.

CAR-mediated targeting of NK cells overcomes tumor immune escape caused by ICAM-1 downregulation.

Journal: Journal for immunotherapy of cancer

Published: December 24, 2023

C/EBPβ-dependent autophagy inhibition hinders NK cell function in cancer.

C/EBPβ-dependent autophagy inhibition hinders NK cell function in cancer.

Journal: Nature communications

Published: December 18, 2023

Live-cell imaging for analysis of the NK cell immunological synapse.

Live-cell imaging for analysis of the NK cell immunological synapse.

Journal: Methods in cell biology

Published: July 29, 2023

Preclinical assessment of CAR-NK cell-mediated killing efficacy and pharmacokinetics in a rapid zebrafish xenograft model of metastatic breast cancer.

Preclinical assessment of CAR-NK cell-mediated killing efficacy and pharmacokinetics in a rapid zebrafish xenograft model of metastatic breast cancer.

Journal: Frontiers in immunology

Published: July 07, 2023

Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo.

Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo.

Journal: Frontiers in immunology

Published: May 21, 2023

Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting.

Inability of granule polarization by NK cells defines tumor resistance and can be overcome by CAR or ADCC mediated targeting.

Journal: Journal for immunotherapy of cancer

Published: December 14, 2020

"UniCAR"-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells.

"UniCAR"-modified off-the-shelf NK-92 cells for targeting of GD2-expressing tumour cells.

Journal: Scientific reports

Published: November 19, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026